Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	685.45	675.04	482.38	401.86	365.98	353.87
Revenue Growth (YoY)	30.93%	39.94%	20.04%	9.80%	3.42%	15.46%
Cost of Revenue	11.25	10.88	6.48	5.39	5.28	5.58
Gross Profit	674.2	664.16	475.89	396.47	360.7	348.29
Selling, General & Admin	314.71	280.32	184.26	152.85	122.36	105.33
Research & Development	249.12	246.89	184.35	130.99	113.86	114.76
Operating Expenses	563.83	527.21	368.61	283.84	236.22	220.09
Operating Income	110.37	136.95	107.28	112.63	124.48	128.2
Interest & Investment Income	25.25	24.54	17.28	3.56	0.53	3.4
Legal Settlements	-	-	-	-14	-	-
Pretax Income	136.12	161.49	124.56	116.19	125.01	131.6
Income Tax Expense	2.12	20.28	18.42	14.77	12.49	25.59
Net Income	133.99	141.21	106.14	101.42	112.51	106.01
Preferred Dividends & Other Adjustments	1.49	1.48	0.64	0.13	-	-
Net Income to Common	132.51	139.73	105.5	101.29	112.51	106.01
Net Income Growth	13.53%	33.04%	4.66%	-9.86%	6.13%	12.56%
Shares Outstanding (Basic)	104	103	104	107	116	115
Shares Outstanding (Diluted)	116	113	112	116	126	124
Shares Change (YoY)	5.07%	1.55%	-3.64%	-7.94%	1.42%	1.33%
EPS (Basic)	1.28	1.35	1.02	0.95	0.97	0.92
EPS (Diluted)	1.14	1.23	0.94	0.87	0.89	0.85
EPS Growth	8.36%	30.85%	8.05%	-2.25%	4.71%	10.39%
Free Cash Flow	177.16	195.9	126.9	119.91	167.42	150.73
Free Cash Flow Per Share	1.53	1.73	1.14	1.03	1.33	1.21
Gross Margin	98.36%	98.39%	98.66%	98.66%	98.56%	98.42%
Operating Margin	16.10%	20.29%	22.24%	28.03%	34.01%	36.23%
Profit Margin	19.33%	20.70%	21.87%	25.20%	30.74%	29.96%
Free Cash Flow Margin	25.85%	29.02%	26.31%	29.84%	45.75%	42.59%
EBITDA	111.33	137.75	108.32	113.89	125.96	128.73
EBITDA Margin	16.24%	20.41%	22.46%	28.34%	34.42%	36.38%
D&A For EBITDA	0.96	0.8	1.04	1.26	1.48	0.53
EBIT	110.37	136.95	107.28	112.63	124.48	128.2
EBIT Margin	16.10%	20.29%	22.24%	28.03%	34.01%	36.23%
Effective Tax Rate	1.56%	12.56%	14.79%	12.71%	9.99%	19.45%

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q